ON THE ISSUE OF EXPANDING THE INDICATIONS OF THE USE OF AN IMMUNOMODULATING DRUG IN THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN YOUNG CHILDREN
The data on the safety and effectiveness of the use of the domestic immunomodulating preparation Polyoxidonium® (azoximer bromide) in children are summarized in the following pages. Polyoxidonium has an immunomodulatory (including interferon-inducing), detoxication and anti-inflammatory effect that...
Main Author: | V. F. Uchaikin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Diagnostics and Vaccines"
2017-09-01
|
Series: | Detskie Infekcii (Moskva) |
Subjects: | |
Online Access: | https://detinf.elpub.ru/jour/article/view/309 |
Similar Items
-
The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
by: Sergey V Efimov, et al.
Published: (2021-03-01) -
Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
by: Sergey V Efimov, et al.
Published: (2021-06-01) -
Role of immunocorrection therapy in comprehensive treatment of patients with inflammatory diseases of female genital organs
by: Natalia A. Shchukina, et al.
Published: (2020-05-01) -
Place of immunomodulators in the treatment of pelvic inflammatory diseases
by: I V Kuznetsova, et al.
Published: (2016-10-01) -
Immunomodulators for the prevention and treatment of acute respiratory infections: Efficacy of azoximer bromide
by: V A Bulgakova
Published: (2014-12-01)